Note: Ingredients listed on restricted chemical lists
EC/CAS
68515-40-2
Name of the chemical
Benzyl octyl phthalate (B79P)
Concentration
>25.0-<35.0%
EC/CAS
28553-12-0
Name of the chemical
Di-isononyl phthalate(DINP),5
Concentration
>5.0-<15.0%
EC/CAS
64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
<5.0%
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
<5.0%
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
<5.0%
EC/CAS
26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
<1.0%
General Information
Revision date
2009-06-02
Product name
BETALINK(TM) K1
Icons in SDS
Company Information
company name
The Dow Chemical Company
GHS Information
Signal word
WARNING! May cause eye irritation. May cause skin irritation. A component in this
Section 2
SECTION 2: Hazards identification
OSHA Hazards Emergency Overview Color: Black Physical State: Paste Odor: Solvent
Signal word
WARNING! May cause eye irritation. May cause skin irritation. A component in this mixture has been shown to be a skin sensitizer. May cause central nervous system effects. May cause respiratory tract irritation. May cause allergic respiratory reaction. Isolate area.
Potential health effects
Eye Contact: May cause eye irritation. Skin Contact: Prolonged contact may cause skin irritation with local redness. Skin Absorption: Prolonged skin contact is unlikely to result in absorption of harmful amounts. ®(TM)*Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow Skin Sensitization: A component in this mixture has been shown to be a skin sensitizer. Inhalation: At room temperature, exposure to vapor is minimal due to low volatility. Vapor from heated material may cause respiratory irritation and other effects. May cause central nervous system effects. Symptoms may include headache, dizziness and drowsiness, progressing to incoordination and unconsciousness. For the minor component(s): Excessive exposure may cause irritation to upper respiratory tract (nose and throat) and lungs. May cause pulmonary edema (fluid in the lungs.) Decreased lung function has been associated with overexposure to isocyanates. Effects may be delayed. This material contains mineral and/or inorganic fillers. There is essentially no potential for inhalation exposure to these fillers incidental to industrial handling due to the physical state. Respiratory Sensitization: A component in this mixture may cause an allergic respiratory response. MDI concentrations below the exposure guidelines may cause allergic respiratory reactions in individuals already sensitized. Asthma-like symptoms may include coughing, difficult breathing and a feeling of tightness in the chest. Occasionally, breathing difficulties may be life threatening. Ingestion: Low toxicity if swallowed. Small amounts swallowed incidentally as a result of normal handling operations are not likely to cause injury; however, swallowing larger amounts may cause injury. May cause abdominal discomfort or diarrhea. May cause nausea and vomiting. Effects of Repeated Exposure: Contains component(s) which have been reported to cause effects on the following organs in animals: Liver. Kidney. Blood. Lung. Tissue injury in the upper respiratory tract and lungs has been observed in laboratory animals after repeated excessive exposures to MDI/polymeric MDI aerosols. Xylene is reported to have caused hearing loss in laboratory animals upon exposure to high concentrations; such effects have not been reported in humans. Although one early inhalation study on ethylbenzene reported an adverse effect on the testes, recent, more comprehensive studies have not shown this effect.
Cancer information
Lung tumors have been observed in laboratory animals exposed to respirable aerosol droplets of MDI/Polymeric MDI (6 mg/m3) for their lifetime. Tumors occurred concurrently with respiratory irritation and lung injury. Current exposure guidelines are expected to protect against these effects reported for MDI. Ethylbenzene has been shown to cause cancer in laboratory animals. Birth Defects/Developmental Effects: Exaggerated doses of xylene given orally to pregnant mice resulted in an increase in cleft palate, a common developmental abnormality in mice. In animal inhalation studies, xylene caused toxicity to the fetus but did not cause birth defects. Contains component(s) which did not cause birth defects in animals; other fetal effects occurred only at doses toxic to the mother. Contains component(s) which caused birth defects in laboratory animals only at doses toxic to the mother. Contains component(s) which, in laboratory animals, have been toxic to the fetus at doses nontoxic to the mother. In laboratory animals, MDI/polymeric MDI did not cause birth defects; other fetal effects occurred only at high doses which were toxic to the mother. Reproductive Effects For the phthalate ester(s) In laboratory animals, excessive doses toxic to the parent animals caused decreased weight and survival of offspring.